Mentice receives an order of EUR 1,733,200 for simulation solutions from a world leading MedTech company

Friday, December 22, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader and existing customer of Mentice, has signed an agreement to acquire Mentice VIST® simulation solutions for EUR 1,733,200. The majority of the Mentice VIST® systems are to be deployed in the main APAC markets.

“We are pleased to announce this contract as part of our continued growth in the Medical Device Industry. This is a significant order that underlines our ongoing commitment to supporting physician’s procedural and device adoption initiatives through our global medical device clients.”, states Göran Malmberg, CEO of Mentice AB.

The order will be recognized for order value in 2023 while the majority of the revenue will be recognized in 2024.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB